In this study, METTL3, YTHDF2, HNRNPC, YTHDF1, and RBM15 were identified as the commonly prognostic m6A RNA methylation modulators for HCC in both TCGA and ICGC projects. Here, METTL3 is linked to hepatocellular carcinoma.